mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
XAV-939 |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
Topotecan |
FIMM |
pan-cancer |
AAC |
-0.15 |
0.2 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
marinopyrrole A |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.2 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |